关键词: Developmental lung disease Medications Pediatric Pulmonary hypertension WSPH classification

Mesh : Humans Hypertension, Pulmonary / therapy diagnosis physiopathology epidemiology etiology Child Antihypertensive Agents / therapeutic use

来  源:   DOI:10.1016/j.ccm.2024.04.001   PDF(Pubmed)

Abstract:
Pulmonary hypertension (PH) may manifest at any age, including during childhood. While pediatric PH frequently associates with early life alterations that cause occult or overt pulmonary vascular disease, all forms of PH seen in adults are also found in children, although with different degrees of prevalence according to PH subtype. PH-specific medications, rapid implementation of therapeutic advances, multidisciplinary teams for improved child and family support, and programs to facilitate successful transition to adult care have contributed to substantial improvement in survival to adulthood.
摘要:
肺动脉高压(PH)可能在任何年龄出现,包括童年。虽然小儿PH经常与导致隐匿性或明显的肺血管疾病的早期生活改变有关,在成人中看到的所有形式的PH也在儿童中发现,尽管根据PH亚型有不同的患病率。特定于PH的药物,快速实施治疗进展,多学科团队,以改善儿童和家庭支持,和计划,以促进成功过渡到成人护理有助于大幅改善成年期的生存。
公众号